New!
Portfolio
Login
/
Sign Up
Search
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
close
close
Send us Feedback
Natus Medical (BABY)
SUMMARY
BULLS
BEARS
TOPICS
DATA CENTRAL
STOCK CHART
SEC FILINGS
BALANCE
INCOME
CASH FLOW
Topic Listing for Natus Medical
Ability Market Sell Products Depends Receipt Domestic Foreign
Abstentions Broker Non-votes
Accounting Treatment
Accounts Receivable
Accrued Liabilities
Acquired In-process Research Development
Acquired Olympic Medical 2006 Including Cool-cap Product Final
Acquisition
Acquisition Alpine Biomed
Acquisition Bio-logic System Corp
Acquisition Bio-logic Systems Corp
Acquisition Business
Acquisition Expands Neurology Product Lines Adds Growth Opportunities
Acquisition Hawaii Medical Llc
Acquisition Neurocom International Inc
Acquisition Schwarzer Gmbh Neurology Division
Acquisition Xltek
Acquisitions
Acquisitions Included In-process Research Development Assets Iprd Assigned
Acquisitions Included In-process Research Development Assets Iprd Hope
Additional Agreements
Address Provided Separate Cover
Adjustments Changes Capitalization Merger Asset Sale
Administration Plan
Adverse Economic Conditions Markets Operate Harm Business
Advertising Costs
Affirmative Covenants
Aggregate Option Exercises Last Year-end Values
Aggregated Option Exercises Last Fy-end Values
Agreement 2007 Between
Aiver
Algo Newborn Hearing Screening Products
Allowance Doubtful Accounts
Alpine Biomed
Alpine Biomed Holdings Corp
Amended Restated 2000 Stock Awards Plan
Amendment
Amendment Credit Facility
Amendment Restated Plan Outstanding Awards
Amendment Termination Plan
Amortization Intangible Assets Acquired Through Business Combinations
Announced Had Entered Agreement Acquire Bio-logic Systems
Announced Had Entered Agreement Acquire Excel-tech Ltd
Application Critical Accounting Policies
Appointment Principal Officers
Approval Amended Restated 2000 Stock Awards Plan
Arrangement Agreement Means Certain Dated 2007 Among Borrower
Audit Committee
Audit Committee Financial Expert
Audit Fees
Auditor Fees Incurred Natus 2004 2005
Auditor Fees Incurred Natus 2006 2005
Auditor Fees Incurred Natus 2007 2006
Auditor Fees Incurred Natus 2008 2007
Backlog
Balance Mobility
Balance Mobility Products
Basic Diluted Earnings Per Common Share
Basic Diluted Net Income Loss Per Common Share
Basic Diluted Net Income Loss Per Share
Basis Presentation
Basis Pro Forma Presentation
Because Rely Distributors Sub-distributors Sell Products Most Markets
Because Rely Distributors Sub-distributors Sell Products Some Markets
Become Subject Litigation Due Likely Volatility Public Market
Benefical Ownership Reporting Compliance
Beneficial Ownership Reporting Compliance
Bio-logic
Bio-logic Acquisition
Bio-logic Acquisition Wells Fargo Bank Financing
Bio-logic Integration
Bio-logic Systems
Bio-logic Systems Corp
Black-scholes Inputs
Board Directors Committee Meetings
Board Directors Recommendation
Board Directors Recommends Vote
Board Independence
Board Recommends Vote Election Each Engibous Moore
Board Structure Committee Composition
Brian Kowalchyk Westpark Capital Analyst
Business
Business Combinations
Business Combinations Goodwill Intangible Assets
Business Compensation Philosophy
Business Harmed Competitors Establish Cooperative Relationships Large Medical
Business Harmed Fda Determines Failed Comply Applicable Regulations
Business Harmed Fda Determines Failed Substantially Comply Applicable
Business Suffer Required Revise Labeling Promotional Materials Fda
Capitalized Software Development Costs
Carrying Value Intangible Assets
Carrying Value Intangible Assets Goodwill
Cash Compensation
Cash Compensation Element
Cash Equivalents
Cautionary Information Regarding Forward Looking Statements
Cautionary Information Regarding Forward-looking Statements
Cautionary Information Regarding Forward-looking Statements Natus
Cautionary Information Regarding Forward-looking Statements-natus
Cautionary Information Regarding Forward-looking Statements-xltek
Certain Beneficial Owners Management
Certain Relationships Policies Related Party Transactions
Certain Relationships Related Transactions
Certain Significant Risks Uncertainties
Certificate
Certification
Changes Internal Control Over Financial Reporting
Changes Internal Controls
Changes Registrants Certifying Accountant
Changes Securities Proceeds
Closes Public Offering
Code Business Conduct Ethics
Code Conduct Ethics
Commitments
Commitments Contingencies
Common Stock
Communicating Board
Communicating Board Directors
Company-owned Facilities
Comparative Consolidated Financial Statements
Comparison 2003 2002
Comparison 2004 2003
Comparison 2005 2004
Comparison 2006 2005
Comparison 2007 2006
Comparison 2008 2007
Compensation Chief Executive Officer
Compensation Committee
Compensation Committee Interlocks Insider Participation
Compensation Committee Report
Competition
Completed Acquisition Bio-logic Numerous Risks Associated
Completed Acquisition Bio-logic Systems Corp Numerous Risks
Completed Acquisition Xltek Cash Used Substantially Available
Completed Acquisition Xltek Cash Used Substantially Then-available
Completed Number Acquisitions Expect Complete Additional Future Numerous
Completion Acquisition Disposition Assets
Compliance Securities Exchange Act 1934
Comprehensive Income
Comprehensive Income Loss
Comprehensive Loss
Comprehensive Loss Deficit
Computerized Polysomnography Diagnostic Sleep Analysis
Concluding Paragraph Signatures Follow Next Page
Condensed Combined Financial Statements
Conditions
Conditions Arrangement
Conditions Issuance Shares
Conditions Merger
Conditions Simultaneous Stock Purchase
Conduct Business Pending Merger
Conference Call
Consent Ernst Young Llp
Consent Independent Auditors
Consent Independent Registered Accounting Firm
Consent Independent Registered Public Accounting Firm
Consideration Issuance Shares
Consolidated Results
Contingencies
Continues Signatures Next Page
Contractual Obligations
Controls Procedures
Corporate Governance Principles Board Matters
Corporate Transaction Costs
Costs Associated Exit Disposal Activities
Creation Direct Financial Obligation
Credit Agreement Wells Fargo Bank
Credit Facility
Credit Terms
Cumulative Voting
Customer Service Support
Customers
Data Management Products
David Nierenberg Investment Management Analyst
Deadline Receipt Stockholder Proposals Annual Shareholder Meetings
Debt Credit Arrangements
Deferred Income Taxes
Deferred Revenue
Deferred Stock Compensation
Deltamed
Demand Some Products Depends Capital Spending Policies Customers
Depend Key Employees Competitive Market Skilled Personnel Without
Devices Systems
Diagnostic Eeg Monitoring Product Lines
Diagnostic Electroencephalograph Eeg Monitoring
Diagnostic Electroencephalograph Eeg Monitoring Product Lines
Diagnostic Electromyography Emg Product Lines
Diagnostic Hearing Assessment
Diagnostic Hearing Assessment Audiologists Ent Physicians
Diagnostic Hearing Assessment Navigator Audx Pro Scout Cochlea-scan
Diagnostic Hearing Assessment Product Lines
Diagnostic Hearing Supply Products
Diagnostic Polysomnography Psg Monitoring
Diagnostic Polysomnography Psg Monitoring Product Lines
Diagnostic Sleep Analysis Polysomnography Psg
Diagnostic Sleep Analysis Product Lines
Direct Sales
Director Compensation
Director Independence
Director Stock Option Plan
Directors Executive Officers
Directors Executive Officers Registrant
Distributor Sales
Dividend Policy
Dividends
Documents Incorporated Reference
Domestic Sales
Earnings Per Share
Ecitals
Ecurity Greement
Eeg Monitoring Neurology
Egative Ovenants
Election Directors
Electromyography Emg
Elements Compensation
Eligibility
Employee Benefit Plan
Employee Stock Purchase Plan
Employees
Employment Agreement
Employment Agreements Change Control Arrangements
Entry Material Definitive Agreement
Environmental Health Safety Regulation Government Adversely Affect Operations
Epresentations Arranties
Equity Compensation Plan Information
Equity-based Compensation
Equity-based Compensation Element
Estimates
Evaluation Disclosure Controls Procedures
Events Default
Exact Name Registrant Specified Charter
Excel-tech Ltd Definitive Agreement
Except Per Share Amounts
Except Per Share Data
Execution Agreement Plan Merger
Execution Version
Executive Bonus Plan
Executive Compensation
Executive Officers
Exhibits
Expands Market Opportunity Eeg Monitoring
Expect Introduce New Product Potentially Expose Greater Products
Experienced Seasonality Sale Products
Explanatory
Fail Comply Healthcare Regulations Face Substantial Penalties Business
Fail Efforts Educate Clinicians Government Agency Personnel Third-party
Fail Efforts Educate Physicians Government Agency Personnel Third-party
Fail Obtain Maintain Necessary Foreign Regulatory Approvals Order
Failure Obtain Necessary Fda Clearances Approvals Comply Regulations
Fair Value Financial Instruments
Fda Regulation
Fdas Premarket Clearance Approval Requirements
Federal Income Tax Information
Ffirmative Ovenants
Fifth Amendment Amended Restated Credit Agreement
Financial Guidance
Financial Instruments Risk Management
Financial Statement Schedule
Financial Statements
Financial Statements Business Acquired
Financial Statements Exhibits
Financial Statements Pro Forma Information Exhibits
Fischer-zoth
Following Acquisitions Implemented Integration Restructuring Activities Disruptive Operations
Foreign Currency
Foreign Currency Translation
Foreign Regulation
Form 10-k
Form 10-q
Form 8-k
Form Assignment
Form Election Purchase
Form Rights Certificate
Former Name Address Changed Since Last Report
Forward Looking Statements
Future Changes Technology Market Conditions Result Adjustments Recorded
Future Liquidity
General
General Compensation Philosophy
General Information
General Provisions
Goodwill
Government Assistance
Government Regulation
Governmental Environmental Health Safety Regulations Adversely Affect Operations
Grant Number
Group Purchasing Organizations
Growth Recent Depended Substantially Completion Acquisitions Not Able
Guidance
Guidance Increased
Guidelines Mandating Universal Newborn Hearing Screening Not Continue
Guidelines Mandating Universal Newborn Screening Not Continue Develop
Guidelines Requiring Universal Newborn Screening Not Continue Develop
Hawaii Medical
Health Care Providers Not Adequately Reimbursed Procedures Conducted
Hearing
Hearing Screening
Hearing Screening Overview
Hearing Screening Supply Products
Hedging Relationships
History Losses Variable Quarterly Results Seasonality Sale Products
Impairment Long-lived Assets
Income Taxes
Increased Sales Through Group Purchasing Organizations High Volume
Increases Full-year 2006 Revenue Earnings Guidance
Indemnification
Indemnification Contribution
Indemnifications
Independent Registered Public Accounting Firm
Index
Index Consolidated Financial Statements
Index Exhibits
Industrial Road
Industrial Road San Carlos California 94070
Information Concerning Nominees Incumbent Directors
Initiated Changes Information Systems Disrupt Business Financial Results
Integral Part Financial Statements
Integration Plan
Integration Restructuring Plan
Interim Consolidated Financial Statements Significant Accounting Policies
Internal Control Over Financial Reporting
Internal Software Development Costs
International Sales
Internet Availability Proxy Materials
Intra-operative Monitoring Iom
Intra-operative Monitoring Products
Inventories
Inventory Carried Lower Cost Market Value
Investorrelationsnatuscom
Jaundice Management
Jaundice Management Products
Ken Traverso Natus Medical Incorporated Sales Marketing
Kevin Kotler Analyst
Leased Facilities
Leases
Leverage Ratio Means Date Determination Borrower Subsidiaries Consolidated
Liability Product Warranties
License Intellectual Property Rights Parties Adversely Affected Licensors
Line Credit
Liquidity Capital Resources
List Subsidiaries
Llegality
Long-lived Assets
Long-lived Assets Goodwill
Long-term Debt
Lose Ability Net Operating Loss Carryforwards Adversely Affect
Lose Ability Net Operating Loss Credit Carryforwards Adversely
Lose Relationship Supplier Key Product Components Deteriorates Not
Management Presentation
Managements Report Internal Control Over Financial Reporting
Manufacturing
Marketing
Marketing Sales
Markets Very Competitive United States Sell Certain Products
Material Modifications Rights Security Holders
Material Weaknesses Adequacy Internal Control Over Financial Reporting
Material Weaknesses Adequacy Internal Controls Over Financial Reporting
Matt Dolan Roth Capital Analyst
Medical Devices Related Supplies
Medical Devices Related Supplies Segment
Memo
Mended Estated Ecurity Greement
Mended Estated Evolving Ine Redit Ote
Mended Estated Redit Greement
Mergers Consolidations Change Control
Methods Voting
Monitoring Systems Neurology
Monitoring Systems Neurology Electroencephalograph Eeg
Mutual Covenants
Name Person Filing Proxy Statement Other Registrant
Nascor
Nature Operations
Natus Algo Newborn Hearing Screening Product Line
Natus Echo-screen Hearing Screening Monitoring Product Line
Natus Medical
Natus Medical Acquire Bio-logic Systems
Natus Medical Amend Stockholder Rights Plan
Natus Medical Announces 2009 Financial Results Increases Guidance
Natus Medical Announces Preliminary 2008 Full Results Provides
Natus Medical Announces Preliminary 2009 Results
Natus Medical Announces Pricing Public Offering
Natus Medical Announces Record 2008 Financial Results
Natus Medical Announces Record 2008 Full Results
Natus Medical Appoints Deloitte Touche Llp New Auditors
Natus Medical Completes Acquisition Excel-tech Ltd
Natus Medical Incorporated
Natus Medical Promotes Steven Murphy Chief Financial Officer
Natus Neonatal Ltd
Negative Covenants
Neometrics
Neometrics Inc
Net Change Non-cash Working Capital Balances
Net Income Loss Per Common Share
Net Loss Per Common Share
Neurocom
Neurologic Function
Neurological Assessment Treatment Options
New Accounting Pronouncements
Newborn Brain Injury
Newborn Brain Injury Product Line
Newborn Care
Newborn Care Products
Newborn Hearing Screening
Newborn Hearing Screening Product Lines
Newborn Hearing Screening Techniques
Newborn Hearing Screening United States
Newborn Metabolic Screening
Nominating Governance Committee
Nominees
Nominees Election
Non-employee Director Compensation
Non-employee Director Compensation Table 2005
Non-gaap Adjustments
Non-gaap Financial Measures
Not Able Preserve Value Intellectual Property Because Protect
Not Able Preserve Value Products Intellectual Property Because
Not Successful Integrating Businesses Acquire Perform Projected
Not Successful Integrating Businesses Acquire Such Accretive Earnings
Notes Condensed Consolidated Financial Statements
Notice
Notice 2006 Annual Meeting Stockholders
Notice 2007 Annual Meeting Stockholders
Notice 2008 Annual Meeting Stockholders
Notice 2009 Annual Meeting Stockholders
Notice Annual Meeting Stockholders
Notice Restricted Stock Grant
Notice Withdrawal
Number
Off-balance Sheet Arrangements
Olympic
Olympic Cool-cap Product Subject Greater Products Liability Exposure
Onditions
Operating Leases
Operating Results
Operating Results Decline Not Succeed Developing Acquiring Marketing
Operating Results Suffer Because Exposure Foreign Currency Exchange
Operating Results Suffer Because Foreign Currency Exchange Rate
Operating Results Suffer Future Changes Technology Market Conditions
Operating Results Suffer Subject Protracted Infringement Claim
Operating Results Suffer Subject Protracted Infringement Claim Significant
Operations Restricted Terms Debt Adversely Affect
Opinions
Option Exercises Stock Vested
Option Grants 2004
Option Grants 2005
Options
Organization
Organization Significant Accounting Policies
Orm Inancial Ovenant Ompliance Ertificate
Other
Other Benefits
Other Covenants Parent
Other Events
Other Income Expense Net
Other Income Net
Other Information
Other Liabilities
Other Matters
Other Newborn Care Product Lines
Other Regulations
Oting Greement
Overview
Part
Part Other Information
Past Relied Sales Newborn Screening Products Majority Revenue
Patrick Winton Sterne Agee Leach Analyst
Performance
Person Means Natural Corporation Limited Liability Trust Joint
Plan
Plan Expand International Operations Result Increased Costs Subject
Plan Expected Result Operating Cost Reduction 2009
Policy Audit Committee Pre-approval Permissible Non-audit Services Independent
Policy Director Recommendations Nominations
Potential Payments Termination Change Control
Power Attorney
Preferred Stock
Preferred Stock Rights Agreement
Presentation
Principles Consolidation
Pro Forma Adjustments
Pro Forma Condensed Combined Financial Statements
Pro Forma Condensed Combined Statement Operations
Pro Forma Financial Information
Pro Forma Net Income Loss Per Share
Pro Forma Net Income Per Share
Produce Line Customer Geographic Information
Product Families
Product Liability Suits Against Result Expensive Time Consuming
Product Line Customer Geographic Information
Products
Property Equipment
Property Plant Equipment
Proposal 1-election Directors
Proposal 2-ratification Appointment Independent Registered Public Accounting Firm
Proposal 3-approval Amended Restated 2000 Stock Awards Plan
Proposals
Proprietary Rights
Provides 2010 Guidance
Provides 2010 Non-gaap Earnings Per Share Guidance 060
Provision Income Tax
Provision Recovery Income Taxes
Proxy Solicitation Costs
Proxy Solicited Behalf Board Directors
Pulmonary Function
Pulmonary Function Products
Purchase Agreement
Purchase Commitments
Purchase Sale Delivery Securities
Purchased In-process Research Development Expenses
Pursuant
Pursuant 906 Sarbanes-oxley Act 2002
Pursuant Securities Exchange Act 1934
Quantitative Qualitative Disclosures Market Risk
Quarterly Period 2005
Quarterly Period 2006
Quarterly Period 2007
Quarterly Period 2009
Questions Answers Proxy Materials Annual Meeting
Quorum Requirement
Reasons Amendment Restatement
Receipt
Receipt Consent
Received Clearance Fda Market New Product Potentially Expose
Recent Accounting Pronouncements
Recent Gaap Accounting Pronouncements
Recently Adopted Standards
Recently Issued Accounting Standards
Recitals
Reclassifications
Redit Greement
Registered Public Accounting Firm
Registrants Telephone Number Including Area Code
Reiterates 2008 Financial Guidance Representing Earnings Growth
Related Party Transactions
Relied Expect Continue Rely Sales Algo Hearing Screening
Relied Expect Continue Rely Sales Algo Screening Product
Relied Expect Continue Rely Sales Newborn Screening Products
Remainder Page Been Left Intentionally Blank
Remainder Page Intentionally Left Blank
Remainder Page Left Blank Intentionally
Remediation Previously Reported Material Weakness
Report Audit Committee Board Directors
Report Compensation Committee Board Directors
Report Independent Auditors
Report Independent Registered Public Accounting Firm
Representations Warranties
Representations Warranties Natus
Representations Warranties Parent Merger Sub
Research Development
Research Development Capitalized Software Costs
Research Development Costs
Reserve Product Warranties
Resignation Letter William New Phd Dated 2004
Restricted Stock Activity
Restricted Stock Awards
Restricted Stock Unit Agreement
Restricted Stock Units
Restructuring
Restructuring Charges
Restructuring Plan
Restructuring Reserve
Results Operations
Results Operations Financial Condition
Return Receipt Requested
Revenue Product Category
Revenue Product Family Category
Revenue Recognition
Revoking Proxy
Sale Common Stock
Sales Efforts Through Group Purchasing Organizations High Volume
San Carlos 94070
Schedule
Schwarzer Neurology
Sean Mcmahon Kennedy Capital Analyst
Seasonality Revenue
Securities Authorized Issuance Equity Compensation Plans
Securities Exchange Act 1934
Securities Registered Pursuant Act Common Stock 0001 Par
Security Ownership Certain Beneficial Owners Management
Security Ownership Table
See Accompanying Notes
Segment Customer Geographic Information
Segment Geographic Information
Segment Information
Segment Results
Segmented Information
Selected Quarterly Financial Data
Separate Stock Certificate
Share Capital
Share Purchase Loan
Share-based Compensation
Share-based Compensation Expense
Shelf Offering Priced Close Market 2008
Shipping Terms
Short Term Investments
Short-term Investments
Signature
Signatures
Significant Subsidiaries Registrant
Software Systems
Software Systems Segment
Sonamed
Statement Cash Flows
Statement Operations
Statement Stockholders Equity
Statements Integral Part Financial
Stock Appreciation Rights
Stock Awards Plan
Stock Awards Plans
Stock Bonus Awards
Stock Offering
Stock Option Plans
Stock Options
Stock Performance Graph
Stock Purchase
Stock-based Compensation
Stock-based Compensation Plan
Stockholder Record
Stockholder Rights Plan
Stockholder Rights Plan Anti-takeover Provisions Charter Documents Delaware
Stockholders Equity
Stockholders Equity Deficit
Submission Matters Vote Security Holders
Subscription Agreement
Subsequent Event
Subsequent Events
Summary Amended Restated 2000 Stock Awards Plan
Summary Compensation Table
Summary Proposals
Summary Rights
Summary Significant Accounting Policies
Supplemental Income Statement Schedule
Suppliers Fail Comply Applicable Regulations Sales Products Delayed
Supplies Services
Table Contents
Tax Deductibility Executive Compensation
Term Restated Plan
Termination Agreement
Termination Amendment Waiver
Thermoregulation
Thermoregulation Products
Third-party Reimbursement
Triggering Events Accelerate Increase Direct Financial Obligation
Unable Service Debt
Unable Service Debt Maintain Sufficient Liquidity Working Capital
Uncertain Tax Positions
United States
United States Securities Exchange Washington 20549
United States Sell Newborn Hearing Screening Products Mature
United States Sell Products Mature Market Intensely Competitive
Unregistered Sales Equity Securities
Unregistered Sales Equity Securities Proceeds
Updates Guidance
Valuation Allowance Deferred Tax Assets
Vents Efault
Vote Internet Http Wwweproxycom Baby Quick Easy Immediate
Vote Mail
Vote Phone Toll Free 1-800-560-1965 Quick Easy Immediate
Vote Required
Votes Required Each Proposal
Voting Procedures
Warranties Parent Subco
Water Street Healthcare Partners
Ways Vote Proxy
Wells Fargo Credit Facility
Wells Fargo Revolving Credit Facility
Wells Fargo Senior Credit Facility
Wells Fargo Term Commitment
Xhibit
Xhibit 161
Xhibit 991
Xltek
Xltek Integration
Bet you've never seen portfolio analytics like these.
Introducing
SigFig
— from the creators of
Take Tour